Nanoviricides Stock (AMEX: NNVC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 36.552K |
Day Range | - - - |
52 Wk Range | 1.000 - 2.000 |
Market Cap | $13.664M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 42 |
Short Interest | 0.88% |
Days to Cover | 4.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nanoviricides (AMEX: NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Nanoviricides (AMEX: NNVC) was reported by EF Hutton on Friday, February 16, 2024. The analyst firm set a price target for 6.50 expecting NNVC to rise to within 12 months (a possible 460.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Nanoviricides (AMEX: NNVC) is $1.16 last updated Today at April 17, 2024 at 8:00 PM EDT.
There are no upcoming dividends for Nanoviricides.
Nanoviricides’s Q3 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.